Opportunity ID: 327707

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-21-001
Funding Opportunity Title: Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 – Clinical Trials Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.233 — National Center on Sleep Disorders Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 15, 2020
Last Updated Date: Jun 15, 2020
Original Closing Date for Applications: Dec 09, 2020
Current Closing Date for Applications: Dec 09, 2020
Archive Date: Jan 14, 2021
Estimated Total Program Funding: $2,512,000
Award Ceiling: $400,000
Award Floor:

Eligibility

Eligible Applicants: State governments
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Public and State controlled institutions of higher education
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Public housing authorities/Indian housing authorities
Private institutions of higher education
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support hybrid effectiveness-implementation trials for heart, lung, blood, and sleep (HLBS) diseases in the inpatient setting. NHLBI is seeking applications that propose a trial testing an implementation strategy (or strategies) that was developed utilizing an implementation research framework and that aims to increase implementation of an evidence-based practice(s). This FOA intends to support applications that propose a multidisciplinary research team that includes expertise in inpatient clinical research, implementation research, and biostatistics. Any applicant proposing a trial that meets the requirements of this FOA is eligible to apply, regardless of participation in Planning Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U34) (RFA-HL-18-018).
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-21-001.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or after May 25, 2020 PKG00262211 Nov 09, 2020 Dec 09, 2020 View

Package 1

Mandatory forms

327707 RR_SF424_2_0-2.0.pdf

327707 PHS398_CoverPageSupplement_5_0-5.0.pdf

327707 RR_OtherProjectInfo_1_4-1.4.pdf

327707 PerformanceSite_2_0-2.0.pdf

327707 RR_KeyPersonExpanded_2_0-2.0.pdf

327707 PHS398_ResearchPlan_4_0-4.0.pdf

327707 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

327707 RR_Budget_1_4-1.4.pdf

327707 RR_SubawardBudget30_1_4-1.4.pdf

327707 PHS398_ModularBudget_1_2-1.2.pdf

327707 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T07:56:20-05:00

Share This Post, Choose Your Platform!

About the Author: